Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001388910 | SCV001590063 | pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2022-06-28 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with PEX12-related conditions. ClinVar contains an entry for this variant (Variation ID: 1075350). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Gln111*) in the PEX12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX12 are known to be pathogenic (PMID: 9090384, 9632816, 21031596). This variant is present in population databases (no rsID available, gnomAD 0.01%). |
Baylor Genetics | RCV001388910 | SCV004201457 | likely pathogenic | Peroxisome biogenesis disorder 3A (Zellweger) | 2022-03-19 | criteria provided, single submitter | clinical testing |